“As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, and Patient Protections” stated Duane Boise CEO MMJ International Holdings.
Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!
“As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, and Patient Protections” stated Duane Boise CEO MMJ International Holdings.